Annual CFF
$7.97 M
+$7.77 M+3886.50%
31 December 2023
Summary:
Mereo BioPharma annual cash flow from financing activities is currently $7.97 million, with the most recent change of +$7.77 million (+3886.50%) on 31 December 2023. During the last 3 years, it has fallen by -$39.37 million (-83.16%). MREO annual CFF is now -92.39% below its all-time high of $104.80 million, reached on 31 December 2021.MREO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$594.00 K
-$47.38 M-101.27%
30 September 2024
Summary:
Mereo BioPharma quarterly cash flow from financing activities is currently -$594.00 thousand, with the most recent change of -$47.38 million (-101.27%) on 30 September 2024. Over the past year, it has dropped by -$8.50 million (-107.51%). MREO quarterly CFF is now -101.27% below its all-time high of $46.78 million, reached on 30 June 2024.MREO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$46.19 M
-$8.50 M-15.54%
30 September 2024
Summary:
Mereo BioPharma TTM cash flow from financing activities is currently $46.19 million, with the most recent change of -$8.50 million (-15.54%) on 30 September 2024. Over the past year, it has increased by +$38.21 million (+479.29%). MREO TTM CFF is now -15.54% below its all-time high of $54.69 million, reached on 30 June 2024.MREO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3886.5% | -107.5% | +479.3% |
| 3 y3 years | -83.2% | - | - |
| 5 y5 years | +402.8% | - | - |
MREO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -92.4% | +3886.5% | -101.3% | at low | -15.5% | >+9999.0% |
| 5 y | 5 years | -92.4% | +206.5% | -101.3% | at low | -15.5% | >+9999.0% |
| alltime | all time | -92.4% | +206.5% | -101.3% | at low | -15.5% | >+9999.0% |
Mereo BioPharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$594.00 K(-101.3%) | $46.19 M(-15.5%) |
| June 2024 | - | $46.78 M(>+9900.0%) | $54.69 M(+585.9%) |
| Dec 2023 | $7.97 M(+3886.5%) | $0.00(-100.0%) | $7.97 M(0.0%) |
| Sept 2023 | - | $7.91 M(>+9900.0%) | $7.97 M(>+9900.0%) |
| June 2023 | - | $67.00 K | $67.00 K |
| Dec 2022 | $200.00 K(-99.8%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $104.80 M(+121.4%) | - | - |
| Dec 2020 | $47.34 M(-732.3%) | - | - |
| Dec 2019 | -$7.49 M(+184.3%) | - | - |
| Dec 2018 | -$2.63 M(-105.8%) | - | - |
| Dec 2017 | $45.60 M(-45.9%) | - | - |
| Dec 2016 | $84.34 M | - | - |
FAQ
- What is Mereo BioPharma annual cash flow from financing activities?
- What is the all time high annual CFF for Mereo BioPharma?
- What is Mereo BioPharma annual CFF year-on-year change?
- What is Mereo BioPharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Mereo BioPharma?
- What is Mereo BioPharma quarterly CFF year-on-year change?
- What is Mereo BioPharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Mereo BioPharma?
- What is Mereo BioPharma TTM CFF year-on-year change?
What is Mereo BioPharma annual cash flow from financing activities?
The current annual CFF of MREO is $7.97 M
What is the all time high annual CFF for Mereo BioPharma?
Mereo BioPharma all-time high annual cash flow from financing activities is $104.80 M
What is Mereo BioPharma annual CFF year-on-year change?
Over the past year, MREO annual cash flow from financing activities has changed by +$7.77 M (+3886.50%)
What is Mereo BioPharma quarterly cash flow from financing activities?
The current quarterly CFF of MREO is -$594.00 K
What is the all time high quarterly CFF for Mereo BioPharma?
Mereo BioPharma all-time high quarterly cash flow from financing activities is $46.78 M
What is Mereo BioPharma quarterly CFF year-on-year change?
Over the past year, MREO quarterly cash flow from financing activities has changed by -$8.50 M (-107.51%)
What is Mereo BioPharma TTM cash flow from financing activities?
The current TTM CFF of MREO is $46.19 M
What is the all time high TTM CFF for Mereo BioPharma?
Mereo BioPharma all-time high TTM cash flow from financing activities is $54.69 M
What is Mereo BioPharma TTM CFF year-on-year change?
Over the past year, MREO TTM cash flow from financing activities has changed by +$38.21 M (+479.29%)